Allied Copper Announces $2.0 million Non-Brokered
Vancouver, British Columbia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Allied Copper Corp. (TSX-V: CPR, OTCQB: CPRRF) (the
Globe Newswire31-01-2023, 05:45
London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024 11-06-2024, 01:33